Stock screenerAll disclosures →
EDGAR →
ONMD
Conviction 8HealthcareScan · Thu, Jun 25, 2026ONMD$0.5905-6.42%
ResistanceSupportVol 14Insider buyVol MA14 532.23K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.5905
Change-6.42%
Gap-4.58%
Rel volume1.21×
Avg volume446.91K
Avg $ vol275.44K
SMA 200.6482
SMA 500.8285
SMA 2001.14
Price vs 50-28.73%
Price vs 200-48.34%
MA stackbearish
50/200 cross—
Supertrenddown · 0.7597
RSI (14)40
MACD hist0.01
MACD crossbull · 1d
Stoch %K / %D39 / 41
ADX (14)32
+DI / −DI19 / 25
RSI divergence—
MACD divergenceBullish
ATR %+12.57%
ADR %10.52%
52w high3.14
52w low0.4520
From 52w high-81.19%
Above 52w low+30.64%
New 52w highNo
SqueezeOff
Bollinger width56.23%
%B0.34
Donchian pos27.54%
Donchian high0.8549
Donchian low0.4900
AVWAP (52w high)1.41
vs AVWAP high-58.24%
AVWAP (52w low)1.54
vs AVWAP low-61.55%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d1.21×
Avg vol (14d)532.23K
Avg vol (20d)446.91K
Avg $ vol (20d)275.44K
Market cap32.14M
RS 3m (vs SPY)-35.87%
RS 6m (vs SPY)-59.57%
RS line new highNo
Trend template1/8
Technical rank9.9
1 week-1.96%
1 month-33.27%
3 months-31.78%
6 months-57.82%
1 year-13.44%
YTD-51.60%
P/E-11.48
P/B-7.88
P/S23.65
P/FCF-4.28
EPS-0.0600
Div yield—
ROE68.67%
ROA-185.87%
Debt/Eq-0.25
Current0.27
EV/EBITDA-3.43
Gross margin-37.01%
Net margin-206.11%
Rev growth111.35%
EPS growth72.35%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value32.92M
Revenue96K
Net income-2.45M
Gross profit-380K
Free cash flow-7.52M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out54.43M
Employees23
ListedWed, Nov 8, 2023
Free float19.1M
Float %37.4%
Short interest457.29K
Days to cover1.6d
Short volume31.7%
Squeeze score16 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank9.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.9950
Support0.4900
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ONMD
No recent disclosed trades by Congress in ONMD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ONMD · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kosasa Thomas Director · Common Stock · 2026-05-18 | Buy | 268.82K | $250K | 2026-05-18 | 2026-05-20 |
Kosasa Thomas Director · Common Stock · 2026-04-23 | Buy | 280.9K | $250K | 2026-04-23 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Other | — | — | 2026-04-01 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Grant | 219.43K | $182K | 2026-04-01 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Buy | 903.61K | $750K | 2026-04-01 | 2026-04-24 |
Kosasa Thomas Director · Common Stock · 2026-02-06 | Buy | 595.24K | $500K | 2026-02-06 | 2026-04-24 |
SEC filings
EDGAR filings in ONMD
No recent SEC filings on file for ONMD.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.